TrovaGene (TROV)
Add to Watchlists Create an AlertTROV Key Stats
| Income Statement | |
| Revenue TTM | 0.4504M |
| Revenue Quarterly YoY Growth | 383.7% |
| EPS Diluted TTM | -0.8797 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -11.57M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -3875% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 108.46M |
| Enterprise Value | 87.55M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 50.01 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -1.373M |
| Return on Equity | -1422% |
TROV News
- Nasdaq stocks posting largest percentage increases May 20
- Nasdaq stocks posting largest percentage increases May 16
- Organovo: Get Rich Or Die Tryin' May 15
- TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Conditio... May 15
- Trovagene (TROV) Tops Q1 EPS by 2c Street Insider May 14
- Trovagene, Inc. Announces First Quarter 2013 Earnings PR Newswire May 14
- TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report May 14
- The 4 Healthcare Companies Investors Should Be Watching May 14
- Weekly Stock Watch - Week Of May 13, 2013 May 11
- Detecting Investment Potential In Medical Diagnostics Companies May 7
TROV Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). TrovaGene is up 18.88% over the last year vs S&P 500 Total Return up 28.33%, Oramed Pharmaceuticals down 97.13%, and Tesaro up 1.04%.
TROV Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these TROV related companies
Pro Ratings for TROV
Pro Report PDF for TROV
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TROV Pro Report PDF
Pro Strategies Featuring TROV
Did TrovaGene make it into our Pro Portfolio Strategies?
TROV Profile
Sector: Healthcare
Industry: Biotechnology
Other TROV Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TROV | 6.95 | +0.61 | +9.62% | 108.46M |
